Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Again? Is it support or faith?

<< Previous

Bullboard Posts

Next >>

Comment by wofatson May 11, 2024 11:32am

129 Views

Post# 36035199

RE:RE:Again? Is it support or faith?

You may be correct

iled 2024-05-10 13:32 Tx date 2024-05-09	$GUD Knight Therapeutics Inc.	Armoyan, Sime 3 - 10% Security Holder of Issuer Holder: Armco Alberta Inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-439,705 -73,900 vol $5.95 each	12,666,200
Filed 2024-05-10 13:30 Tx date 2024-05-08	$GUD Knight Therapeutics Inc.	Armoyan, Sime 3 - 10% Security Holder of Issuer Holder: Armco Alberta Inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,190 -200 vol $5.95 each	12,740,100
Older filings
Filed 2024-05-08 06:43 Tx date 2024-05-07	$GUD Knight Therapeutics Inc.	Armoyan, Sime 3 - 10% Security Holder of Issuer Holder: Armco Alberta Inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-89,250 -15,000 vol $5.95 each	12,740,300